The Effect of Colchicine on the Occurrence of Atrial Fibrillation After Cardiac Surgery
Recruiting
Phase 4
Interventional Study
Coronary Artery Disease
Atrial Fibrillation
Coronary Artery Bypass Grafting
Colchicine
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Trial phase
- Phase 4
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 140 (estimated)
- Sponsor
- Tomsk Cardiology Research Institute · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Development of a new comprehensive method for perioperative prevention of atrial fibrillation paroxysms in cardiac surgery patients at the hospital stage.
It is planned to recruit 70 patients who will undergo pericardial fenestration during the operation using the original technique during coronary artery bypass grafting (Patent No. 2647626 C1 Russian Federation), and will be prescribed colchicin…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. Elective coronary artery bypass grafting on pump;
2. signed informed consent to participate in the study.
Exclusion Criteria:
1. Reduced left ventricular ejection fraction (≤35%);
2. Valvular heart disease requiring surgical correction;
3. Liver failure with an increase in …
Contacts